Journal Club: Medicine

Medical · Peripheral Brain, LLC

Journal Club: Medicine icon
291 ratings
4.4
Installs
10K+
Price
$6.99
Advertisements

Journal Club: Medicine screenshots

Journal Club: Medicine screenshot 1Journal Club: Medicine screenshot 2Journal Club: Medicine screenshot 3Journal Club: Medicine screenshot 4Journal Club: Medicine screenshot 5Journal Club: Medicine screenshot 6Journal Club: Medicine screenshot 7Journal Club: Medicine screenshot 8Journal Club: Medicine screenshot 9Journal Club: Medicine screenshot 10Journal Club: Medicine screenshot 11Journal Club: Medicine screenshot 12
Advertisements

Most medical reference apps try to cover everything. Journal Club: Medicine does the opposite: it narrows in on the landmark trials of internal medicine, the studies that changed how physicians practice, and presents each one as a short summary written by physicians. That focus is the most distinctive thing about it, and it shapes everything else.

The app draws on Wiki Journal Club and delivers at least three new reviews each month, mixing classic papers with contemporary ones. It is a paid app at $6.99, with no ads and no in-app purchases, and it has been on Google Play since March 2013, with the most recent update in May 2024. More than 10,000 installs and a 4.4 average from 291 ratings suggest a settled, well-used tool rather than a novelty.

This is for clinicians and trainees in internal medicine and its subspecialties, people who want the practice-changing studies close at hand rather than a comprehensive index of everything published. If you are a student learning to appraise evidence, the format works in your favor too, because each entry is short enough to read in a spare moment.

What a summary actually gives you

Each entry is built around a concise bottom line, backed by the major points that matter for interpreting the trial. The developer describes these as bite-size summaries that clinicians can digest quickly, and the structure reflects that: you get the gist without working through the full paper first. Think of it as a way to refresh your memory of a study you half-remember, or to get oriented before you read the original.

The summaries link out to PubMed and the primary literature, which is the part I find most useful in principle. A short summary is a starting point, not a substitute for the paper, and having the citation one tap away keeps the app honest about that. You can read the condensed version, then go straight to the source if the details matter for a decision.

The developer is clear about the editorial line: the app favors trials that change how medicine is practiced, the kind internists and medical subspecialists should know well. The 1981 NCDS trial of dialysis in end-stage renal disease is the example given for the kind of paper that gets covered, while a newly published trial of lixisenatide in diabetes is the kind that is less likely to appear. That is a deliberate trade-off, and it tells you what to expect from the catalog.

Finding the trial you half-remember

A catalog of landmark trials is only useful if you can get to the right one quickly, and the app offers several ways in. You can sort by name, date, specialty or disease, which covers the usual ways a clinician thinks about a paper: by what it studied, by when it ran, or by whose practice it changed. Integrated search handles the case where you know the name but not where it sits in the catalog.

Favorites let you keep a personal shortlist of the studies you return to, whether for teaching, for an exam, or because they come up in your specialty. Sharing summaries with colleagues is supported as well, so a relevant trial can be passed along to a team without everyone tracking down the same citation separately. None of this is elaborate, and that is fine for a reference tool.

The sorting options are worth thinking about, because they reveal how the content is organized. If you work in nephrology, sorting by specialty or disease gets you to the trials that shaped your field; if you are preparing for a general medicine exam, sorting by date gives you a rough historical spine of the evidence. Search is the fallback when neither approach fits.

Keeping current without reinstalling

The content updates automatically between app versions, so new reviews arrive without you having to wait for a store update. That matters for an app whose value depends on a steady stream of new material: at least three new reviews arrive each month, covering both classic and contemporary publications. The May 2024 update was described as minor bug fixes, with the automatic content updates continuing as usual.

The app was renamed to include the word Medicine, but the developer notes that the heart, soul and content stayed the same. If you encounter the older name in a reference or a colleague's home screen, it is the same tool. That continuity is reassuring for anyone who has relied on it over the years, and it means the rename does not signal a change in direction.

The pace of additions is the thing to weigh. Three or more reviews a month accumulates steadily over a year, but this is not a feed of everything published in internal medicine, and the developer does not pretend otherwise. The catalog grows in the direction of studies that stood the test of time, which is a slower and more selective process than covering each week's journals.

What you need before you start

There is not much to set up. The developer describes the interface as simple and intuitive, and given that the core job is reading short summaries and sorting a list, there is no reason to expect a steep learning curve.

The one practical requirement is the content itself being current, which the automatic updates handle between versions.

Because the catalog is selective by design, the useful preparation is mental rather than technical: go in expecting landmark trials and the summaries that explain why they mattered, rather than a comprehensive index of recent publications. The developer's own example, favoring the 1981 dialysis trial over a fresh diabetes study, sets that expectation clearly.

Who gets the most from a landmark-trial library

The clearest fit is a practicing internist or medical subspecialist who wants the defining trials of the field within reach, whether for teaching, for a journal club meeting, or for the moment a colleague mentions a study by name and you want the bottom line rather than a blank look. Residents and fellows preparing for board exams are a natural second audience, since the app's editorial line tracks the studies that exams and attendings tend to expect you to know.

It also suits anyone who teaches evidence-based medicine and needs a compact way to introduce a trial before sending learners to the paper. The summary gives the shape of the study, the links give the depth, and the sorting options make it easy to assemble a short reading list by specialty or disease.

The narrower fit is anyone who needs to keep up with the newest publications in a subspecialty. The developer is candid that a hot-off-the-press trial is less likely to be covered than a study from decades ago that changed practice, so the app is a poor stand-in for current-awareness reading. It is a library of what has endured, not a news feed, and that distinction should decide whether the $6.99 is worth it for you.

A settled reference for the trials that stuck

Journal Club: Medicine is a focused, physician-written reference to the landmark trials of internal medicine, with concise bottom lines, major points, sorting by name, date, specialty or disease, search, favorites and links to the primary literature.

The trade-off is the editorial line: classic and practice-changing studies come first, and the newest publications are less likely to appear. If your need is to know the studies that shaped internal medicine, that trade-off works in your favor; if your need is this week's literature, it does not.

I would point this at internists, subspecialists and trainees who want the defining trials of the field in a form they can read in a few minutes and follow up on when it counts. It is a small, specific tool that does one job carefully, and for the right reader that is exactly the point.

The short verdict

A focused, physician-written library of landmark internal medicine trials that suits clinicians and trainees, not readers chasing the newest papers.

What's new

Fixed some minor bugs. As always, Journal Club: Medicine's content automatically updates in between app versions.

App specs

  • VersionVaries with device
  • UpdatedMay 15, 2024
  • Downloads10K+
  • RequiresVaries with device
  • Price$6.99
  • Age ratingEveryone

Journal Club: Medicine: frequently asked questions

What kind of studies does Journal Club: Medicine cover?

The app centers on landmark internal medicine trials, mainly those that change practice and matter to internists and subspecialists. The developer gives the 1981 NCDS trial of dialysis in end-stage renal disease as an example of the kind of paper that gets covered. A newly published trial of lixisenatide in diabetes is the kind that is less likely to appear.

How often is new content added?

At least three new reviews arrive each month, covering classic and contemporary landmark publications. Content updates automatically between app versions, so new reviews arrive without waiting for a store update. The May 2024 release was described as minor bug fixes, with the automatic updates continuing as usual.

Does the app cost anything or show ads?

It is a paid download at $6.99, with no ads and no in-app purchases. That makes it a one-time cost rather than an ongoing commitment. The content keeps updating automatically after you buy it.

Can I find a specific trial and share it with colleagues?

Yes. The app includes integrated search and lets you sort trials by name, date, specialty or disease, which covers the usual ways of tracking down a paper. You can also mark favorites for the studies you return to and share summaries with colleagues. Each summary links out to PubMed and the primary literature for the full paper.

Is this a good way to keep up with the newest medical research?

It is built for landmark and practice-changing studies rather than current-awareness reading. The developer is explicit that a classic trial such as the 1981 dialysis study is more likely to be covered than a study hot off the press. If you need the latest publications in a subspecialty, this app is organized around what has endured instead.

Pros

  • Summaries written by physicians
  • At least three new reviews monthly
  • Sort by name, date, specialty, disease
  • Links out to PubMed and primary literature
  • No ads and no in-app purchases

Cons

  • Paid download at $6.99
  • Favors landmark trials over recent publications
  • Newest subspecialty studies less likely covered

eFreeware is independent and is not affiliated with Peripheral Brain, LLC. We do not host app files: downloads come from the official Google Play listing. App names, icons and screenshots belong to their owners. Developer contact: [email protected]. Developer privacy policy.